| 1 | | - | Assembly Concurrent Resolution No. 33 CHAPTER 26 Relative to Lymphedema Awareness Day. [ Filed with Secretary of State April 04, 2019. ] LEGISLATIVE COUNSEL'S DIGESTACR 33, Gloria. Lymphedema Awareness Day.This measure would declare March 6, 2019, as Lymphedema Awareness Day in California.Digest Key Fiscal Committee: NO Bill TextWHEREAS, Lymphedema (LE) is a serious chronic disease that plagues nearly 10 million Americans who are either born with the condition or who develop it as a result of trauma, surgical insult, radiation therapy, or a combination of these factors; andWHEREAS, LE is a disease that occurs when the bodys natural lymphatic drainage system is damaged or blocked or does not develop properly and the lymphatic fluid within a given area, such as the arm, leg, torso, head, or neck, is unable to drain properly. This results in extreme swelling that can cause pain and significantly impairs mobility, function, and the quality of life for the affected person; andWHEREAS, The National Cancer Institute predicts a 42-percent increase in cancer survivors 65 years of age or older by 2020, and as many as 1.5 to 3 million Medicare beneficiaries who are cancer survivors will require treatment for their LE; andWHEREAS, Worldwide, the World Health Organization estimates that over 150 million people have secondary LE and an additional 120 million people are infected with lymphatic filariasis, which leads to lymphedema; andWHEREAS, Underdiagnosing and undertreating LE patients cost health care providers and health care coverage policies or plans, including the federal Medicare Program, untold millions of dollars every year because, if LE is left untreated, the potential for infection is greatly increased, possibly spreading in the course of a few hours, and requiring immediate treatment on an emergency basis; andWHEREAS, Several thousand Californians will be put at risk or will develop LE each year as a consequence of cancer treatment, surgical insult, or physical trauma; andWHEREAS, Without professional treatment and selfcare, the accumulation of lymphatic fluid results in the gross distention of the lymph-filled body part and chronic infections that can become lifethreatening without prompt treatment; andWHEREAS, LE often leaves its victims disfigured, as well as physically and emotionally disabled; andWHEREAS, Many LE patients are breast cancer survivors who have undergone surgery or lymph node removal, often in combination with subsequent radiation therapy. However, similar treatments for colon cancer, melanoma, and uterine, ovarian, and cervical cancer can also cause LE; andWHEREAS, Persons at risk for LE must apply a regimen of self-care to prevent or delay the onset of symptoms that is nearly as rigorous as self-care requirements for patients already afflicted with LE; andWHEREAS, Timely diagnosis and treatment are often not available to patients, particularly those in rural areas, making LE more difficult to manage with more negative health consequences due to delays in diagnosing and treating the condition; andWHEREAS, It is important to recognize the tireless advocates and health care providers who spend so much of their time and resources battling this painful and destructive condition that affects so many members of the community; andWHEREAS, World Lymphedema Day is recognized on March 6 of each year; now, therefore, be itResolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares March 6, 2019, as Lymphedema Awareness Day in California; and be it furtherResolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution. |
|---|
| 1 | + | Enrolled April 01, 2019 Passed IN Senate March 28, 2019 Passed IN Assembly March 07, 2019 CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION Assembly Concurrent Resolution No. 33Introduced by Assembly Member Gloria(Coauthors: Assembly Members Aguiar-Curry, Arambula, Bauer-Kahan, Berman, Bigelow, Bloom, Boerner Horvath, Bonta, Brough, Burke, Carrillo, Cervantes, Chau, Chen, Chiu, Choi, Chu, Cooley, Cooper, Dahle, Daly, Diep, Eggman, Frazier, Friedman, Gabriel, Gallagher, Cristina Garcia, Eduardo Garcia, Gipson, Gonzalez, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager-Dove, Kiley, Lackey, Levine, Limn, Low, Mathis, Mayes, McCarty, Medina, Melendez, Mullin, Muratsuchi, Obernolte, ODonnell, Patterson, Petrie-Norris, Quirk, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Robert Rivas, Blanca Rubio, Salas, Santiago, Smith, Mark Stone, Ting, Voepel, Weber, Wicks, and Wood)February 20, 2019 Relative to Lymphedema Awareness Day.LEGISLATIVE COUNSEL'S DIGESTACR 33, Gloria. Lymphedema Awareness Day.This measure would declare March 6, 2019, as Lymphedema Awareness Day in California.Digest Key Fiscal Committee: NO Bill TextWHEREAS, Lymphedema (LE) is a serious chronic disease that plagues nearly 10 million Americans who are either born with the condition or who develop it as a result of trauma, surgical insult, radiation therapy, or a combination of these factors; andWHEREAS, LE is a disease that occurs when the bodys natural lymphatic drainage system is damaged or blocked or does not develop properly and the lymphatic fluid within a given area, such as the arm, leg, torso, head, or neck, is unable to drain properly. This results in extreme swelling that can cause pain and significantly impairs mobility, function, and the quality of life for the affected person; andWHEREAS, The National Cancer Institute predicts a 42-percent increase in cancer survivors 65 years of age or older by 2020, and as many as 1.5 to 3 million Medicare beneficiaries who are cancer survivors will require treatment for their LE; andWHEREAS, Worldwide, the World Health Organization estimates that over 150 million people have secondary LE and an additional 120 million people are infected with lymphatic filariasis, which leads to lymphedema; andWHEREAS, Underdiagnosing and undertreating LE patients cost health care providers and health care coverage policies or plans, including the federal Medicare Program, untold millions of dollars every year because, if LE is left untreated, the potential for infection is greatly increased, possibly spreading in the course of a few hours, and requiring immediate treatment on an emergency basis; andWHEREAS, Several thousand Californians will be put at risk or will develop LE each year as a consequence of cancer treatment, surgical insult, or physical trauma; andWHEREAS, Without professional treatment and selfcare, the accumulation of lymphatic fluid results in the gross distention of the lymph-filled body part and chronic infections that can become lifethreatening without prompt treatment; andWHEREAS, LE often leaves its victims disfigured, as well as physically and emotionally disabled; andWHEREAS, Many LE patients are breast cancer survivors who have undergone surgery or lymph node removal, often in combination with subsequent radiation therapy. However, similar treatments for colon cancer, melanoma, and uterine, ovarian, and cervical cancer can also cause LE; andWHEREAS, Persons at risk for LE must apply a regimen of self-care to prevent or delay the onset of symptoms that is nearly as rigorous as self-care requirements for patients already afflicted with LE; andWHEREAS, Timely diagnosis and treatment are often not available to patients, particularly those in rural areas, making LE more difficult to manage with more negative health consequences due to delays in diagnosing and treating the condition; andWHEREAS, It is important to recognize the tireless advocates and health care providers who spend so much of their time and resources battling this painful and destructive condition that affects so many members of the community; andWHEREAS, World Lymphedema Day is recognized on March 6 of each year; now, therefore, be itResolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares March 6, 2019, as Lymphedema Awareness Day in California; and be it furtherResolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution. |
|---|